Skip to content

Bazemore Robert B

Reporting owner on Forms 3, 4 and 5, CIK 1620152.

Bazemore Robert B reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
AKTX · Akari Therapeutics PlcCIK 1541157director12026-10-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing…2026-10-14M exercised+773$0.000419,666Form 4
AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing…2026-10-14M exercised+3,093$0.000422,759Form 4
AKTX · Akari Therapeutics PlcPre-Funded Warrant to Purchase ADSs, derivative2026-10-14M exercised-773$16.160Form 4
AKTX · Akari Therapeutics PlcPre-Funded Warrant to Purchase ADSs, derivative2026-10-14M exercised-3,093$16.160Form 4
AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing…2026-10-05A granted+4,677$7.89918,893Form 4
AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing…2026-08-18A granted+13,100$7.89914,216Form 4
AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative2026-08-18A granted+45,000$045,000Form 4
AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative2026-08-18A granted+15,000$015,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001493152-26-047455 Akari Therapeutics Plc2026-10-16